Inhibition of oncogenic RET signaling by Ad vector-mediated expression of a dominant-negative RET-mutant: implications for medullary thyroid cancer treatment. - Institute for Experimental Gentherapy and Cancer Research

Drosten M, Frilling A, Stiewe T, Pützer BM.

Inhibition of oncogenic RET signaling by Ad vector-mediated expression of a dominant-negative RET-mutant: implications for medullary thyroid cancer treatment.

Eur J Cancer 2002 ; 38:490 Suppl 7 Nov.